MANIFOLD
BrowseUS ElectionNewsAbout
Will we have gene therapy for a major strain of Crohn's disease by 2030?
Mini
6
Ṁ127
2030
26%
chance
1D
1W
1M
ALL
  • "major strain" = 20% or more of cases

  • "have" = approved by the FDA

  • "by 2030" = by Jan 1st 2030

Though, I'm open suggestions.

Health️ MedicineBiotech
Get Ṁ1,000 play money
1 Comment
Sort by:

https://jeremiahengland.substack.com/p/gene-therapy-for-permanently-curing

Related questions

By 2030, will there be a cure to aging?
12% chance
By 2040, will there be a cure to aging?
-7% 1d42% chance
By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
18% chance
Will there be a CRISPR treatment for Ehlers-Danlos Syndromes before 2040?
52% chance
Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027?
59% chance
Will a therapy that substantially slows down or reverses the aging process in humans be developed before 2040?
69% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
79% chance
Will we get a cure for cancer before 2030?
9% chance
Will we have a treatment for Alzheimer's disease that halts the progression of the disease by 2035?
52% chance
Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?

Related questions

By 2030, will there be a cure to aging?
12% chance
Will a therapy that substantially slows down or reverses the aging process in humans be developed before 2040?
69% chance
By 2040, will there be a cure to aging?
42% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
79% chance
By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
18% chance
Will we get a cure for cancer before 2030?
9% chance
Will there be a CRISPR treatment for Ehlers-Danlos Syndromes before 2040?
52% chance
Will we have a treatment for Alzheimer's disease that halts the progression of the disease by 2035?
52% chance
Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027?
59% chance
Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?
BrowseElectionNewsAbout